Cargando…

Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli

BACKGROUND: 2'-Fucosyllactose (2-FL) is a functional oligosaccharide present in human milk which protects against the infection of enteric pathogens. Because 2-FL can be synthesized through the enzymatic fucosylation of lactose with guanosine 5′-diphosphate (GDP)-l-fucose by α-1,2-fucosyltransf...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Won-Heong, Pathanibul, Panchalee, Quarterman, Josh, Jo, Jung-Hyun, Han, Nam Soo, Miller, Michael J, Jin, Yong-Su, Seo, Jin-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442965/
https://www.ncbi.nlm.nih.gov/pubmed/22545760
http://dx.doi.org/10.1186/1475-2859-11-48
_version_ 1782243489108459520
author Lee, Won-Heong
Pathanibul, Panchalee
Quarterman, Josh
Jo, Jung-Hyun
Han, Nam Soo
Miller, Michael J
Jin, Yong-Su
Seo, Jin-Ho
author_facet Lee, Won-Heong
Pathanibul, Panchalee
Quarterman, Josh
Jo, Jung-Hyun
Han, Nam Soo
Miller, Michael J
Jin, Yong-Su
Seo, Jin-Ho
author_sort Lee, Won-Heong
collection PubMed
description BACKGROUND: 2'-Fucosyllactose (2-FL) is a functional oligosaccharide present in human milk which protects against the infection of enteric pathogens. Because 2-FL can be synthesized through the enzymatic fucosylation of lactose with guanosine 5′-diphosphate (GDP)-l-fucose by α-1,2-fucosyltransferase (FucT2), an 2-FL producing Escherichia coli can be constructed through overexpressing genes coding for endogenous GDP- l-fucose biosynthetic enzymes and heterologous fucosyltransferase. RESULTS: The gene for FucT2 from Helicobacter pylori was introduced to the GDP- l-fucose producing recombinant E. coli BL21 star(DE3) strain. However, only small amount of 2-FL was produced in a batch fermentation because the E. coli BL21star(DE3) strain assimilated lactose instead of converting to 2-FL. As an alternative host, the E. coli JM109(DE3) strain which is incapable of assimilating lactose was chosen as a 2-FL producer. Whole cell biosynthesis of 2-FL from lactose was investigated in a series of batch fermentations using various concentrations of lactose. The results of batch fermentations showed that lactose was slowly assimilated by the engineered E. coli JM109(DE3) strain and 2-FL was synthesized without supplementation of another auxiliary sugar for cell growth. A maximum 2-FL concentration of 1.23 g/l was obtained from a batch fermentation with 14.5 g/l lactose. The experimentally obtained yield (g 2-FL/g lactose) corresponded to 20% of the theoretical maximum yield estimated by the elementary flux mode (EFM) analysis. CONCLUSIONS: The experimental 2-FL yield in this study corresponded to about 20% of the theoretical maximum yield, which suggests further modifications via metabolic engineering of a host strain or optimization of fermentation processes might be carried out for improving 2-FL yield. Improvement of microbial production of 2-FL from lactose by engineered E. coli would increase the feasibility of utilizing 2-FL as a prebiotic in various foods.
format Online
Article
Text
id pubmed-3442965
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34429652012-09-15 Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli Lee, Won-Heong Pathanibul, Panchalee Quarterman, Josh Jo, Jung-Hyun Han, Nam Soo Miller, Michael J Jin, Yong-Su Seo, Jin-Ho Microb Cell Fact Research BACKGROUND: 2'-Fucosyllactose (2-FL) is a functional oligosaccharide present in human milk which protects against the infection of enteric pathogens. Because 2-FL can be synthesized through the enzymatic fucosylation of lactose with guanosine 5′-diphosphate (GDP)-l-fucose by α-1,2-fucosyltransferase (FucT2), an 2-FL producing Escherichia coli can be constructed through overexpressing genes coding for endogenous GDP- l-fucose biosynthetic enzymes and heterologous fucosyltransferase. RESULTS: The gene for FucT2 from Helicobacter pylori was introduced to the GDP- l-fucose producing recombinant E. coli BL21 star(DE3) strain. However, only small amount of 2-FL was produced in a batch fermentation because the E. coli BL21star(DE3) strain assimilated lactose instead of converting to 2-FL. As an alternative host, the E. coli JM109(DE3) strain which is incapable of assimilating lactose was chosen as a 2-FL producer. Whole cell biosynthesis of 2-FL from lactose was investigated in a series of batch fermentations using various concentrations of lactose. The results of batch fermentations showed that lactose was slowly assimilated by the engineered E. coli JM109(DE3) strain and 2-FL was synthesized without supplementation of another auxiliary sugar for cell growth. A maximum 2-FL concentration of 1.23 g/l was obtained from a batch fermentation with 14.5 g/l lactose. The experimentally obtained yield (g 2-FL/g lactose) corresponded to 20% of the theoretical maximum yield estimated by the elementary flux mode (EFM) analysis. CONCLUSIONS: The experimental 2-FL yield in this study corresponded to about 20% of the theoretical maximum yield, which suggests further modifications via metabolic engineering of a host strain or optimization of fermentation processes might be carried out for improving 2-FL yield. Improvement of microbial production of 2-FL from lactose by engineered E. coli would increase the feasibility of utilizing 2-FL as a prebiotic in various foods. BioMed Central 2012-04-30 /pmc/articles/PMC3442965/ /pubmed/22545760 http://dx.doi.org/10.1186/1475-2859-11-48 Text en Copyright ©2012 Lee et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lee, Won-Heong
Pathanibul, Panchalee
Quarterman, Josh
Jo, Jung-Hyun
Han, Nam Soo
Miller, Michael J
Jin, Yong-Su
Seo, Jin-Ho
Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
title Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
title_full Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
title_fullStr Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
title_full_unstemmed Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
title_short Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
title_sort whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered escherichia coli
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442965/
https://www.ncbi.nlm.nih.gov/pubmed/22545760
http://dx.doi.org/10.1186/1475-2859-11-48
work_keys_str_mv AT leewonheong wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli
AT pathanibulpanchalee wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli
AT quartermanjosh wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli
AT jojunghyun wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli
AT hannamsoo wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli
AT millermichaelj wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli
AT jinyongsu wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli
AT seojinho wholecellbiosynthesisofafunctionaloligosaccharide2fucosyllactoseusingengineeredescherichiacoli